Business Description
Alzamend Neuro is an Atlanta-based company, founded in 2016, that is developing new medical treatments for brain-related conditions such as Alzheimer's disease, bipolar disorder, PTSD, and major depression. Its lead treatment, AL001, combines lithium, proline, and salicylate into a single therapy, while its second program, ALZN002, works by training the body's own immune system to fight Alzheimer's disease. Both treatments are currently being tested in clinical trials.
